Isotopes and Medical Innovation

Bruce Power does more than supply 30 per cent of the electricity used by Ontario’s families and businesses.

The medical isotopes supplied by Bruce Power are vital resources to the medical community, and the company continues to seek ways to expand the types of isotopes it produces. An agreement signed in 2019 brought together Bruce Power, Kinectrics and Framatome with group of a biotechnology and radiopharmaceutical  companies to collaborate on establishing Ontario as a global hub for medical isotopes including research, development, production, processing and export.

By joining forces with the health care sector and research facilities, nuclear energy producers like Bruce Power can continue delivering life-saving medical isotopes to hospitals around the world – improving the quality of life of millions of people in the process.

Medical Worker in Lab

Cobalt-60 and Lutetium-177

Four of Bruce Power’s reactors produce Cobalt-60, an isotope which helps to sterilize 40 per cent of the world’s medical devices, and treat complex forms of cancer – including brain tumours – through non-invasive procedures like the Gamma Knife.

Production of Lutetium-177, a key isotope used to treat prostate cancer, is expected to be enabled at Bruce Power as soon as 2022 thanks to a partnership with Kinectrics and Framatome to advance this innovative project。 

A partnership with Saugeen Ojibway Nation (SON)

银河彩票投注In 2019, The Saugeen Ojibway Nation (SON) and Bruce Power entered into a new collaboration agreement to jointly market new isotopes in support of the global fight against cancer while also focusing on creating new economic opportunities within the SON Territory by establishing new isotope infrastructure。

Learn more at

ISOTOPES VIDEOS

Stay in touch

Sign up for our monthly eNewsletter

* indicates required
爱投彩票开户 利来彩票开户 两个彩票平台刷流水可以赚钱吗 红牛彩票开户 吉林快3开奖 山东11选5开奖 北京28预测 博金光娱乐 海南4+1 河北快3代理